ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,278Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1019

$701K Total Retail Price of All Prescriptions

Rank: 33 out of 1019

655 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,272 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CARVEDILOL 619 537 1 3
CLOPIDOGREL 548 520 2 7
BISOPROLOL FUMARATE 526 459 3 43
ATORVASTATIN CALCIUM 525 460 4 10
LISINOPRIL 520 436 5 2
DIGOXIN 398 371 6 14
FUROSEMIDE 356 332 7 6
PRAVASTATIN SODIUM 337 298 8 16
PLAVIX 335 316 9 11
LEVOTHYROXINE SODIUM 312 306 10 25
AMLODIPINE BESYLATE 289 277 11 4
CRESTOR 283 238 12 13
HYDRALAZINE HCL 270 249 13 34
FAMOTIDINE 267 260 14 82
SIMVASTATIN 263 227 15 5
RAMIPRIL 249 234 16 21
MULTAQ 186 176 17 49
SOTALOL 179 170 18 35
SPIRONOLACTONE 179 171 18 23
WARFARIN SODIUM 176 159 20 9
METOPROLOL TARTRATE 173 155 21 8
CILOSTAZOL 166 162 22 45
LOSARTAN POTASSIUM 161 146 23 17
BYSTOLIC 155 142 24 26
ISOSORBIDE MONONITRATE ER 152 139 25 12
AMIODARONE HCL 142 138 26 22
DIOVAN 142 111 26 20
METOPROLOL SUCCINATE 141 131 28 1
FENOFIBRATE 137 112 29 58
HYDROCHLOROTHIAZIDE 130 111 30 18
VERAPAMIL ER 124 114 31 77
NITROSTAT 118 106 32 27
POTASSIUM CHLORIDE 113 100 33 15
TRIAMTERENE-HCTZ 110 107 34 57
TORSEMIDE 109 98 35 50
LIPITOR 102 95 36 37
PRADAXA 102 88 36 24
ZETIA 92 87 38 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 71 39 28
PANTOPRAZOLE SODIUM 78 63 40 46
ISOSORBIDE DINITRATE 64 45 41 76
COUMADIN 63 50 42 54
ENALAPRIL MALEATE 62 62 43 38
XARELTO 58 57 44 67
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 45 31
OMEPRAZOLE 55 43 46 41
NIASPAN 53 53 47 33
KLOR-CON M20 53 49 47 56
ACEBUTOLOL HCL 51 51 49 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.